Robert N Foley

Summary

Affiliation: United States Renal Data System
Country: USA

Publications

  1. doi request reprint Clinical epidemiology of cardiovascular disease in chronic kidney disease
    Robert N Foley
    Chronic Disease Research Group, School of Medicine, University of Minnesota Twin Cities, Minneapolis, Minnesota 55404, USA
    J Ren Care 36:4-8. 2010
  2. ncbi request reprint NHANES III: influence of race on GFR thresholds and detection of metabolic abnormalities
    Robert N Foley
    United States Renal Data System Coordinating Center, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 18:2575-82. 2007
  3. ncbi request reprint Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999
    Robert N Foley
    United States Renal Data System Coordinating Center, 914 South 8th Street, Suite D 253, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 16:489-95. 2005
  4. doi request reprint Temporal trends in the burden of chronic kidney disease in the United States
    Robert N Foley
    Minnesota School of Medicine, University of Minnesota Twin Cities, Minneapolis, Minnesota 55404, USA
    Curr Opin Nephrol Hypertens 19:273-7. 2010
  5. doi request reprint Serum phosphate and left ventricular hypertrophy in young adults: the coronary artery risk development in young adults study
    Robert N Foley
    United States Renal Data System, Minneapolis, Minn 55404, USA
    Kidney Blood Press Res 32:37-44. 2009
  6. ncbi request reprint Body mass index and survival in peritoneal dialysis patients
    Robert N Foley
    United States Renal Data System, Minneapolis, Minnesota, USA
    Perit Dial Int 25:435-7. 2005
  7. ncbi request reprint Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study
    Robert N Foley
    United States Renal Data System, 914 S 8th St, Suite D253, Minneapolis, MN 55404, USA
    Mayo Clin Proc 80:1270-7. 2005
  8. doi request reprint Long-term outcomes of kidney donors
    Robert N Foley
    Chronic Disease Research Group, Minneapolis, MN 55404, USA
    Curr Opin Nephrol Hypertens 19:129-33. 2010
  9. ncbi request reprint The growing economic burden of diabetic kidney disease
    Robert N Foley
    United States Renal Data System, Minneapolis, MN 55404, USA
    Curr Diab Rep 9:460-5. 2009
  10. ncbi request reprint Hemodialysis access at initiation in the United States, 2005 to 2007: still "catheter first"
    Robert N Foley
    United States Renal Data System, Minneapolis, Minnesota 55404, USA
    Hemodial Int 13:533-42. 2009

Detail Information

Publications93

  1. doi request reprint Clinical epidemiology of cardiovascular disease in chronic kidney disease
    Robert N Foley
    Chronic Disease Research Group, School of Medicine, University of Minnesota Twin Cities, Minneapolis, Minnesota 55404, USA
    J Ren Care 36:4-8. 2010
    ....
  2. ncbi request reprint NHANES III: influence of race on GFR thresholds and detection of metabolic abnormalities
    Robert N Foley
    United States Renal Data System Coordinating Center, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 18:2575-82. 2007
    ..Defining CKD using a single GFR threshold may be disadvantageous for minority populations because metabolic abnormalities are present at higher levels of GFR...
  3. ncbi request reprint Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999
    Robert N Foley
    United States Renal Data System Coordinating Center, 914 South 8th Street, Suite D 253, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 16:489-95. 2005
    ..On an absolute basis, however, the high death rates of patients with CKD may reflect accelerated rates of atherosclerotic vascular disease and congestive heart failure...
  4. doi request reprint Temporal trends in the burden of chronic kidney disease in the United States
    Robert N Foley
    Minnesota School of Medicine, University of Minnesota Twin Cities, Minneapolis, Minnesota 55404, USA
    Curr Opin Nephrol Hypertens 19:273-7. 2010
    ..The purpose of the present review was to examine existing research on temporal trends for CKD and treated end-stage renal disease (ESRD) in the United States...
  5. doi request reprint Serum phosphate and left ventricular hypertrophy in young adults: the coronary artery risk development in young adults study
    Robert N Foley
    United States Renal Data System, Minneapolis, Minn 55404, USA
    Kidney Blood Press Res 32:37-44. 2009
    ..We aimed to determine whether such an association exists in community-dwelling young adults...
  6. ncbi request reprint Body mass index and survival in peritoneal dialysis patients
    Robert N Foley
    United States Renal Data System, Minneapolis, Minnesota, USA
    Perit Dial Int 25:435-7. 2005
  7. ncbi request reprint Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study
    Robert N Foley
    United States Renal Data System, 914 S 8th St, Suite D253, Minneapolis, MN 55404, USA
    Mayo Clin Proc 80:1270-7. 2005
    ..To determine the prevalence of cardiovascular risk factors in the general population based on kidney function...
  8. doi request reprint Long-term outcomes of kidney donors
    Robert N Foley
    Chronic Disease Research Group, Minneapolis, MN 55404, USA
    Curr Opin Nephrol Hypertens 19:129-33. 2010
    ..Hence, the long-term safety of living-kidney donation is an important issue. The purpose of this review was to examine existing research on outcomes among living-kidney transplant donors, with a focus on longer term outcomes...
  9. ncbi request reprint The growing economic burden of diabetic kidney disease
    Robert N Foley
    United States Renal Data System, Minneapolis, MN 55404, USA
    Curr Diab Rep 9:460-5. 2009
    ..Interventions that successfully prevent the development or progression of both conditions have the potential to substantially reduce global health care costs...
  10. ncbi request reprint Hemodialysis access at initiation in the United States, 2005 to 2007: still "catheter first"
    Robert N Foley
    United States Renal Data System, Minneapolis, Minnesota 55404, USA
    Hemodial Int 13:533-42. 2009
    ..Lack of timely access to specialty care appears to limit optimal access...
  11. pmc Creatinine-based glomerular filtration rates and microalbuminuria for detecting metabolic abnormalities in US adults: the National Health and Nutrition Examination Survey 2003-2004
    Robert N Foley
    United States Renal Data System Coordinating Center, Minneapolis, MN 55404, USA
    Am J Nephrol 28:431-7. 2008
    ..This study aimed to quantify diagnostic test characteristics of these measures for detecting metabolic abnormalities...
  12. pmc Cystatin C levels in U.S. adults, 1988-1994 versus 1999-2002: NHANES
    Robert N Foley
    Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA
    Clin J Am Soc Nephrol 4:965-72. 2009
    ..Cystatin C has recently emerged as a promising measure of GFR. To enable further insights into the evolution of CKD in the U.S. population, this study aimed to examine cystatin C levels in U.S. adults...
  13. ncbi request reprint Kidney function and sarcopenia in the United States general population: NHANES III
    Robert N Foley
    United States Renal Data System Coordinating Center, Minneapolis, Minn 55404, USA
    Am J Nephrol 27:279-86. 2007
    ..It is not known whether sarcopenia is associated with levels of kidney function in community-dwelling adults...
  14. ncbi request reprint End-stage renal disease in the United States: an update from the United States Renal Data System
    Robert N Foley
    United States Renal Data System, 914 South 8th Street, Suite S 253, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 18:2644-8. 2007
    ..7% of total Medicare expenditures...
  15. pmc Serum phosphorus levels associate with coronary atherosclerosis in young adults
    Robert N Foley
    US Renal Data System, 914 South 8th Street, Suite S 406, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 20:397-404. 2009
    ..In conclusion, higher serum phosphorus levels, even within the normal range, may be a risk factor for coronary artery atherosclerosis in healthy young adults...
  16. pmc Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: a retrospective analysis
    Robert N Foley
    United States Renal Data System, 914 South 8th Street, Suite S 406, Minneapolis, Minnesota, USA
    BMC Nephrol 9:6. 2008
    ....
  17. ncbi request reprint Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study
    Robert N Foley
    United States Renal Data System, Minneapolis, MN 55404, USA
    Am Heart J 156:556-63. 2008
    ..Calcium-phosphate levels, linked to vascular dysfunction in chronic kidney disease, may represent novel risk factors for coronary heart disease, stroke, and death in community-dwelling adults...
  18. pmc Kidney function and risk triage in adults: threshold values and hierarchical importance
    Robert N Foley
    United States Renal System, Minneapolis, Minnesota 55404, USA
    Kidney Int 79:99-111. 2011
    ..Thus, the albumin-creatinine ratio and eGFR may be at least as efficient for survival-based clinical triage as most other classic risk factors...
  19. pmc Screening for chronic kidney disease complications in US adults: racial implications of a single GFR threshold
    Hassan N Ibrahim
    Department of Medicine, University of Minnesota, USA
    Clin J Am Soc Nephrol 3:1792-9. 2008
    ..73 m(2) identifies the typical metabolic abnormalities related to chronic kidney disease equally well in minority and nonminority adults...
  20. pmc Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapy
    Robert N Foley
    Chronic Disease Research Group, University of Minnesota, Minneapolis, Minnesota, USA
    Clin J Am Soc Nephrol 3:1669-75. 2008
    ..The effects of different hemoglobin targets on blood transfusion requirements have not been well characterized, despite their relevance to clinical decision-making...
  21. pmc Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease
    Robert N Foley
    Chronic Disease Research Group, University of Minnesota, Minneapolis, Minnesota, USA
    Clin J Am Soc Nephrol 5:805-13. 2010
    ..Although left ventricular hypertrophy (LVH) is a characteristic finding in hemodialysis (HD) populations, few risk factors for progressive LVH have been identified...
  22. doi request reprint Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease
    Allan J Collins
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Kidney Dis 53:S71-7. 2009
    ..A CKD screening approach targeting individuals 60 years and older or those with diabetes or hypertension likely would be useful from a public health standpoint...
  23. ncbi request reprint Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death
    Areef Ishani
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 253, Minneapolis, MN 55404, USA
    Nephrol Dial Transplant 23:1682-9. 2008
    ..We aimed to determine the consequences associated with cumulative number of months below target haemoglobin concentrations...
  24. ncbi request reprint The unrecognized prevalence of chronic kidney disease in diabetes
    Rachel J Middleton
    Department of Renal Medicine, Hope Hospital, Stott Lane, Salford M6 8HD, UK, and Chronic Disease Research Group and University of Minnesota, Minneapolis, USA
    Nephrol Dial Transplant 21:88-92. 2006
    ..The aim of this study was to estimate the burden of CKD in patients with diabetes and examine the ability of serum creatinine and albuminuria to detect clinically meaningful CKD compared with estimated glomerular filtration rate (eGFR)...
  25. ncbi request reprint Clinical factors associated with achieving K/DOQI hemoglobin targets in hemodialysis patients
    Suying Li
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota, USA
    Int Urol Nephrol 35:399-405. 2003
    ..Few studies have assessed treatable factors associated with achieving the Kidney Disease Outcomes Quality Initiative (K/DOQI) guideline of hemoglobin values of 11 to 12 g/dL in anemic hemodialysis patients...
  26. ncbi request reprint Anemia and new-onset congestive heart failure in the general Medicare population
    Peter E Sandgren
    Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota 55404, USA
    J Card Fail 11:99-105. 2005
    ..Anemia is associated with disease severity and prognosis for patients with congestive heart failure (CHF). It is unknown whether anemia is associated with the development of new-onset CHF in the elderly...
  27. ncbi request reprint Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study
    Areef Ishani
    Section of Nephrology, Department of Medicine, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota 55417, USA
    Kidney Int 68:311-8. 2005
    ..It is logical to postulate that septicemia, a common macroinflammatory occurrence in dialysis patients, contributes to their large burden of cardiovascular disease...
  28. pmc Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 21:499-506. 2010
    ..These data suggest that increased use of peritoneal dialysis may benefit incident ESRD patients...
  29. pmc Kidney function reference values in US adolescents: National Health And Nutrition Examination Survey 1999-2008
    Blanche M Chavers
    United States Renal Data System, 914 South 8th Street, Suite S 406, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 6:1956-62. 2011
    ..Few data are available on kidney function in normal US adolescents. This study characterizes the distribution of kidney function measures and associated factors...
  30. pmc Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: a randomized trial
    Robert N Foley
    Chronic Disease Research Group and University of Minnesota, Minneapolis, Minnesota, USA
    Clin J Am Soc Nephrol 4:726-33. 2009
    ..The effects of different hemoglobin targets when using erythropoiesis-stimulating agents on quality of life are somewhat controversial, and predictors of change in quality of life in endstage renal disease have not been well characterized...
  31. pmc Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients
    Hassan N Ibrahim
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Clin J Am Soc Nephrol 4:623-9. 2009
    ..The authors aimed to determine prevalence of parenteral iron administration and its contribution to exceeding hemoglobin target levels...
  32. ncbi request reprint Time to target haemoglobin concentration (11 g/dl)--risk of hospitalization and mortality among incident dialysis patients
    Areef Ishani
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Nephrol Dial Transplant 22:2247-55. 2007
    ..We aimed to determine if time required to reach 11 g/dl was associated with increased risk of hospitalization or death among incident dialysis patients...
  33. ncbi request reprint Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect?
    Areef Ishani
    Department of Medicine, Minneapolis Veterans Affairs Medical Center, University of Minnesota, Minneapolis, Minnesota 55417, USA
    Kidney Int 65:1017-25. 2004
    ..We aimed to determine the association between cardioprotective medications and a composite end point of cardiovascular events or death in an incident dialysis cohort...
  34. pmc Cognitive impairment in peritoneal dialysis patients
    Paramjit Kalirao
    Department of Medicine, Hennepin County Medical Center, and University of Minnesota, Minneapolis, MN 55404, USA
    Am J Kidney Dis 57:612-20. 2011
    ..This study describes cognitive impairment occurrence in a peritoneal dialysis cohort compared with a cohort without chronic kidney disease (CKD)...
  35. ncbi request reprint Anemia, hospitalization, and mortality in patients receiving peritoneal dialysis in the United States
    Shuling Li
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 65:1864-9. 2004
    ..The view that hemoglobin levels in peritoneal dialysis patients should be maintained at 11 to 12 g/dL is based largely on the results of studies in hemodialysis patients...
  36. ncbi request reprint Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001
    Haifeng Guo
    United States Renal Data System Coordinating Center, Minneapolis, MN 55404, USA
    Circulation 115:50-8. 2007
    ..Temporal trends regarding the epidemiology of atherosclerotic renovascular disease (ARVD) in dialysis populations are poorly defined...
  37. pmc Hemoglobin level variability: associations with mortality
    David T Gilbertson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 206, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 3:133-8. 2008
    ..4%; intermediate-intermediate (I-I), 6.0%; high-high (H-H), 2.3%; low-intermediate (L-I), 18.3%; intermediate-high (I-H), 31.7%, and low-high (L-H), 40.2%...
  38. ncbi request reprint Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States
    Jon J Snyder
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    J Am Soc Nephrol 15:174-9. 2004
    ..Hemoglobin levels in U.S. hemodialysis and peritoneal populations are similar. However, erythropoietin doses are dramatically higher in hemodialysis patients...
  39. ncbi request reprint Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels
    Tricia L Roberts
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, MN 55404, USA
    Nephrol Dial Transplant 21:1652-62. 2006
    ..Thus, integrating factors predictive of anaemia with actual haemoglobin levels might improve prognostic discrimination...
  40. ncbi request reprint Perihospitalization hemoglobin-epoetin associations in U.S. hemodialysis patients, 1998 to 2003
    Craig A Solid
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Hemodial Int 11:442-7. 2007
    ..8 in 2003). While time to recovery of prehospitalization hemoglobin levels remained constant year to year, epoetin doses and ERI did not, suggesting that optimum perihospitalization anemia management practices have yet to be determined...
  41. pmc Hospital treatment for fluid overload in the Medicare hemodialysis population
    Thomas J Arneson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 5:1054-63. 2010
    ..This study aimed to estimate the magnitude of fluid overload treatment episodes for the Medicare hemodialysis population in hospital settings, including emergency departments...
  42. ncbi request reprint The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002
    Robert N Foley
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, MN 55404, USA
    J Am Soc Nephrol 16:210-8. 2005
    ..Parathyroidectomy rates in U.S. hemodialysis patients increased between 1998 and 2002, a period in which the therapeutic armamentarium for preventing severe hyperparathyroidism expanded considerably...
  43. ncbi request reprint Exceeding hemoglobin target levels in US hemodialysis patients receiving epoetin, 1999 to 2002
    Robert N Foley
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Hemodial Int 11:333-9. 2007
    ..Exceeding hemoglobin level targets has become widespread in the United States and is associated with changes in epoetin dosing practices...
  44. ncbi request reprint Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure
    Robert N Foley
    Nephrology Analytical Services, Hennepin County Medical Center, Minneapolis, Minnesota 55404, USA
    Semin Dial 16:111-7. 2003
    ..There has been explosive growth in observational studies and a heartening, if less dramatic, increase in risk factor intervention trials, suggesting that risk factor modification can lead to meaningful benefit...
  45. ncbi request reprint Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations
    James P Ebben
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 1:1205-10. 2006
    ..Hemoglobin levels in almost 90% of patients are in some degree of flux at any point in time, and the fluctuation is highly associated with clinical complications and provider practices...
  46. ncbi request reprint Anemia and cost in Medicare patients with congestive heart failure
    Craig A Solid
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minnesota, Minneapolis, MN 55404, USA
    Congest Heart Fail 12:302-6. 2006
    ..25 (95% confidence interval, 1.2546-1.2548). Anemia, a common association of CHF in elderly patients, is an antecedent association of increased societal medical expenditure...
  47. doi request reprint The USRDS: what you need to know about what it can and can't tell us about ESRD
    Robert N Foley
    U S Renal Data System, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Clin J Am Soc Nephrol 8:845-51. 2013
    ..Limitations include lack of continuous validation of its methods, lack of complete comorbidity and laboratory data at registration, an initial survival bias, and lack of accuracy of cause-of-death reporting...
  48. doi request reprint Chronic kidney disease awareness, screening and prevention: rationale for the design of a public education program
    Allan J Collins
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Nephrology (Carlton) 15:37-42. 2010
    ..Such assessment is needed to reduce the high burden of ESRD on national health-care systems, which can only be addressed by early screening and active treatment...
  49. ncbi request reprint Clinical epidemiology of parathyroidectomy in hemodialysis patients: the USRDS waves 1, 3, and 4 study
    Yelena Slinin
    University of Minnesota, Minneapolis, Minnesota, USA
    Hemodial Int 11:62-71. 2007
    ..Younger patients on long-term hemodialysis may be at a special risk. Parathyroidectomy risk increases stepwise with alterations in bone metabolism variables, suggesting that a single-threshold management approach may not be ideal...
  50. doi request reprint An improved comorbidity index for outcome analyses among dialysis patients
    Jiannong Liu
    United States Renal Data System Coordinating Center, 914 South 8th Street, Minneapolis, MN 55404, USA
    Kidney Int 77:141-51. 2010
    ..Our index performance was almost identical to the individual comorbid conditions regarding model fit, predictive ability, and effect on inference, and it outperformed the widely used Charlson Comorbidity Index...
  51. ncbi request reprint Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study
    Robert N Foley
    Cardiovascular Special Studies Center, United States Renal Data System, Minneapolis, Minnesota 55404, USA
    Kidney Int 63:1462-7. 2003
    ..Smoking has received surprisingly little research attention in dialysis populations, a group at monumental cardiovascular risk...
  52. ncbi request reprint Anemia and cardiovascular disease, hospitalization, end stage renal disease, and death in older patients with chronic kidney disease
    Shuling Li
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Int Urol Nephrol 37:395-402. 2005
    ..Large observational studies examining the association between anemia and "hard" clinical outcomes are rare in patients with chronic kidney disease (CKD)...
  53. ncbi request reprint Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study
    Yelena Slinin
    United States Renal Data System Coordinating Center, 914 South 8th Street, Suite D 253, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 16:1788-93. 2005
    ....
  54. pmc Cystatin C, mortality risk and clinical triage in US adults: threshold values and hierarchical importance
    Robert N Foley
    United States Renal Data System, Minneapolis, MN, USA
    Nephrol Dial Transplant 26:1831-7. 2011
    ..It has been suggested that cystatin C may be a superior measure of estimated glomerular filtration rate (eGFR) than creatinine-based methods. We aimed to assess the utility of cystatin C for clinical triage in community-based settings...
  55. pmc Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999-2004
    Jon J Snyder
    Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA
    Am J Kidney Dis 53:218-28. 2009
    ..1% of the population (26.3 million people based on the 2000 census) has CKD stages 1 to 4...
  56. pmc Urolithiasis and the risk of ESRD
    Ziad M El-Zoghby
    Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Clin J Am Soc Nephrol 7:1409-15. 2012
    ..The contribution of urolithiasis, if any, to the development of ESRD is unclear...
  57. doi request reprint A novel model of cardiovascular risk based on kidney function
    Robert N Foley
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minn 55404, USA
    Am J Nephrol 34:505-11. 2011
    ..We aimed to identify serum creatinine and eGFR thresholds of maximum sensitivity and specificity (Max(Sn+Sp)) for a composite outcome of coronary heart disease, stroke, and death...
  58. doi request reprint The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis
    Allan J Collins
    U S Renal Data System, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 406, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 4:S5-11. 2009
    ..Public health programs, including the new Medicare chronic kidney disease education benefit, are needed to promote better care of patients who may need dialysis to reduce the high morbidity and mortality in the first year...
  59. doi request reprint Trends in parathyroidectomy rates in US hemodialysis patients from 1992 to 2007
    Suying Li
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Minneapolis, MN 55404, USA
    Am J Kidney Dis 57:602-11. 2011
    ..Parathyroidectomy rates in hemodialysis patients increased from 1992 to 2002, when medication choices to manage secondary hyperparathyroidism expanded...
  60. doi request reprint Mortality from cancer among US hemodialysis patients, 1995-2005
    Robert N Foley
    Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Nephrol 31:518-26. 2010
    ..As ESA doses have more than tripled in the USA since ESAs were introduced, we aimed to compare annual trends in cancer-specific mortality rates among incident maintenance hemodialysis patients...
  61. doi request reprint CKD surveillance using administrative data: impact on the health care system
    Allan J Collins
    US Renal Data System Coordinating Center, University of Minnesota, Minneapolis, MN 55404, USA
    Am J Kidney Dis 53:S27-36. 2009
    ..Long-term trend analyses are needed to determine whether morbidity and mortality rates change based on greater detection and treatment efforts...
  62. doi request reprint Temporal trends in red blood transfusion among US dialysis patients, 1992-2005
    Hassan N Ibrahim
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN, USA
    Am J Kidney Dis 52:1115-21. 2008
    ..Studies addressing patterns and trends in red blood cell transfusion use in US hemodialysis patients surprisingly have received little attention in the last decade...
  63. ncbi request reprint Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries
    Jay L Xue
    United States Renal Data System Coordinating Center, 914 South 8th Street, Suite S 206, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 18:1299-306. 2007
    ..Minority women especially are at greater risk for ESRD than white women. Further studies are needed to determine whether earlier initiation of dialysis is a factor in higher ESRD incidence among minorities...
  64. ncbi request reprint Body size and outcomes on peritoneal dialysis in the United States
    Jon J Snyder
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 64:1838-44. 2003
    ..Being overweight is often cited as a relative contraindication to peritoneal dialysis. Our primary objective was to determine whether actual mortality rates support this opinion...
  65. ncbi request reprint Infectious complications in chronic dialysis patients
    Robert N Foley
    Chronic Disease Research Group, 914 South 8th Street, Suite S 430, Minneapolis, Minnesota 55404, U S A
    Perit Dial Int 28:S167-71. 2008
    ..The present paper focuses on the clinical epidemiology of major bacterial infections in dialysis patients, associations between bacterial infections and cardiovascular disease, and interventions aimed at averting these infections...
  66. ncbi request reprint Septicemia in the United States dialysis population, 1991 to 1999
    Robert N Foley
    United States Renal Data System Coordinating Center, 914 South 8th Street, Suite D 206, Minneapolis, MN 55404, USA
    J Am Soc Nephrol 15:1038-45. 2004
    ..7, 2.0, 2.0, and 1.6 after 5 yr, respectively. Septicemia, which is associated with increased cardiovascular and death risk, has become more common in dialysis patients in the United States...
  67. ncbi request reprint Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study
    Robert N Foley
    Cardiovascular Special Studies Center, United States Renal Data System, Minneapolis, Minnesota, USA
    Kidney Int 62:1784-90. 2002
    ..The long-term prognostic associations of pre- and post-dialysis blood pressures, interdialytic weight gain, and antihypertensive use in hemodialysis patients are unclear...
  68. ncbi request reprint Hypertension is harmful to dialysis patients and should be controlled
    Robert N Foley
    Chronic Disease Research Group and University of Minnesota, Minneapolis, Minnesota, USA
    Semin Dial 20:518-22. 2007
    ..As dialysis patients are at vast cardiovascular risk, these findings suggest that aggressive treatment of hypertension should be the default approach, until large clinical trials show otherwise...
  69. ncbi request reprint Trends in dialysis modality for individuals with acute kidney injury
    Farsad Afshinnia
    St Joseph s Hospital, HealthEast Care System, University of Minnesota, School of Public Health, St Paul, Minnesota, USA
    Ren Fail 31:647-54. 2009
    ..There are no national level data on types of dialysis in use for acute kidney injury (AKI). We aimed to assess trends in dialysis modality for AKI and mortality associated with each modality from 1998 to 2005...
  70. ncbi request reprint Do we know the correct hemoglobin target for anemic patients with chronic kidney disease?
    Robert N Foley
    Chronic Disease Research Group and Department of Medicine, University of Minnesota, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 1:678-84. 2006
    ..Whereas the available evidence suggests that 11 g/dl is a reasonable lower bound for the hemoglobin target range, the upper bound remains to be defined and targets above 13 g/dl cannot be routinely recommended...
  71. ncbi request reprint Infections and cardiovascular disease in patients with chronic kidney disease
    Robert N Foley
    Chronic Disease Research Group, University of Minnesota, Minneapolis, MN 55404, USA
    Adv Chronic Kidney Dis 13:205-8. 2006
    ..Although recent studies suggest that hospitalization for major infections is much more common in nondialysis CKD than in the general population, the prognostic implications remain unexplored...
  72. ncbi request reprint Emerging erythropoiesis-stimulating agents
    Robert N Foley
    Chronic Disease Research Group, 914 South 8th Street, Suite D 253, Minneapolis, MN 55404, USA
    Nat Rev Nephrol 6:218-23. 2010
    ..Such agents include proteins and peptides that activate erythropoietin receptors, non-protein agents, and strategies with targets other than erythropoietin receptors...
  73. ncbi request reprint Cardiac disease in chronic uremia: can it explain the reverse epidemiology of hypertension and survival in dialysis patients?
    Robert N Foley
    Nephrology Analytical Services, Minneapolis Medical Research Foundation and the Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota 55404, USA
    Semin Dial 17:275-8. 2004
    ..A large burden of cardiac disease and insensitive analytical approaches may go a long way toward explaining the reverse epidemiology of hypertension and survival in dialysis patients...
  74. ncbi request reprint Anaemia and the heart: what's new in 2003?
    Robert N Foley
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Nephrol Dial Transplant 18:viii13-6. 2003
    ..Anaemia may not be an 'innocent bystander' in chronic disease; both components of the term 'anaemia of chronic disease' deserve attention...
  75. ncbi request reprint Myocardial disease, anemia, and erythrocyte-stimulating proteins in chronic kidney disease
    Robert N Foley
    Nephrology Analytical Services, Chronic Disease Research Group, Minneapolis Medical Research Foundation and University of Minnesota, Minneapolis, Minnesota, USA
    Rev Cardiovasc Med 6:S27-34. 2005
    ..Several clinical trials have addressed the hypothesis that darbepoetin alfa can effectively treat renal anemia at dose frequencies of once per week, or less often, with positive outcomes...
  76. ncbi request reprint The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis
    Edward F Vonesh
    Baxter Healthcare Corporation, Applied Statistics Center, Round Lake, Illinois 60073, USA
    Kidney Int 66:2389-401. 2004
    ..This study was undertaken to identify key patient characteristics for which the risk of death differs by dialysis modality...
  77. ncbi request reprint Phosphorus comes of age as a cardiovascular risk factor
    Robert N Foley
    Arch Intern Med 167:873-4. 2007
  78. ncbi request reprint Anaemia: cardiovascular adaptations and maladaptive responses in chronic kidney disease
    Robert N Foley
    Directorate of Renal Medicine, Hope Hospital, Salford Royal Hospitals NHS Trust, Salford, UK
    Nephrol Dial Transplant 17:32-4. 2002
    ..Whether this strategy, involving efficient surveillance, early detection, early intervention, and high Hb targets that are independent of the phase of CKD, actually reduces cardiac failure or death remains to be seen...
  79. ncbi request reprint A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease
    Julian R Wright
    Department of Renal Medicine, Hope Hospital, Salford, UK
    Am J Kidney Dis 39:1153-61. 2002
    ....
  80. ncbi request reprint Anaemia management and cardiomyopathy in renal failure
    Rosemary L Donne
    Department of Nephrology, Salford Royal Hospitals NHS Trust, Stott Lane, Salford M6 8HD, UK
    Nephrol Dial Transplant 17:37-40. 2002
    ..Ongoing studies should determine whether a physiologically targeted approach to anaemia management reduces the burden of cardiomyopathy in renal failure...
  81. ncbi request reprint First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
    Colin Baigent
    Clinical Trial Service Unit, Oxford University, Oxford, UK
    Am J Kidney Dis 45:473-84. 2005
    ..Patients with chronic kidney disease are at increased risk for cardiovascular disease, but the efficacy and safety of simvastatin and aspirin are unknown in this patient group...
  82. ncbi request reprint Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion
    Ching M Cheung
    Department of Renal Medicine, Hope Hospital, Salford, England
    J Am Soc Nephrol 13:149-57. 2002
    ..This study reinforces the importance of intrarenal vascular and parenchymal disease in the etiology of renal dysfunction in ARVD...
  83. ncbi request reprint Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease
    Patrick S Parfrey
    Division of Nephrology, Health Sciences Center, Memorial University of Newfoundland, Prince Philip Drive, St John s, Newfoundland A1B 3V6, Canada
    J Am Soc Nephrol 16:2180-9. 2005
    ..Normalization of hemoglobin in incident hemodialysis patients does not have a beneficial effect on cardiac structure, compared with partial correction...
  84. ncbi request reprint Clinical epidemiology of long-bone fractures in patients receiving hemodialysis
    Thomas M Kaneko
    Department of Neurosurgery, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA
    Clin Orthop Relat Res 457:188-93. 2007
    ..Long-bone fractures are common in patients receiving dialysis; their adverse prognostic implications may be linked to major cardiovascular and infectious events...
  85. ncbi request reprint Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis
    Philip A Kalra
    Department of Renal Medicine, Hope Hospital, Salford, United Kingdom
    Kidney Int 68:293-301. 2005
    ..Although atherosclerotic renovascular disease is increasingly recognized in chronic kidney disease, few national level studies have examined its clinical epidemiology...
  86. ncbi request reprint Septicemia, access, cardiovascular disease, and death in dialysis patients
    Conall M O'Seaghdha
    Department of Nephrology, Galway Regional Hospitals, Galway, Ireland
    Perit Dial Int 25:534-40. 2005
  87. ncbi request reprint Comparing the incomparable: hemodialysis versus peritoneal dialysis in observational studies
    Robert N Foley
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Hennepin County Medical Center, Minneapolis, Minnesota 55404, USA
    Perit Dial Int 24:217-21. 2004
    ..Finally, comparisons are complicated by hazards ratios that vary over time, and time-segmented analysis is obligatory. Many types of analytical approaches are needed to begin to appreciate outcome disparities between dialysis therapies...
  88. ncbi request reprint Left ventricular morphology and function in patients with atherosclerotic renovascular disease
    Julian R Wright
    Department of Nephrology, Hope Hospital, Salford, UK
    J Am Soc Nephrol 16:2746-53. 2005
    ..Patients with ARVD exhibit a high prevalence of cardiac morphologic and functional abnormalities at early stages of renal dysfunction. Such patients must be identified early in their disease course to allow risk factor modification...
  89. ncbi request reprint Infections in patients with chronic kidney disease
    Robert N Foley
    Chronic Disease Research Group, Department of Nephrology, University of Minnesota, 914 South 8th Street, Suite D 206, Minneapolis, MN 55404, USA
    Infect Dis Clin North Am 21:659-72, viii. 2007
    ....
  90. doi request reprint Erythropoietin: physiology and molecular mechanisms
    Robert N Foley
    Chronic Disease Research Group, 914 South 8th Street, Suite D 253, Minneapolis, MN 55404, USA
    Heart Fail Rev 13:405-14. 2008
    ....
  91. pmc Mortality trends among Canadian patients receiving dialysis
    Robert N Foley
    Chronic Disease Research Group and the University of Minnesota, Minneapolis, Minn, USA
    CMAJ 177:1055-6. 2007
  92. ncbi request reprint Acute variation in cognitive function in hemodialysis patients: a cohort study with repeated measures
    Anne M Murray
    Department of Medicine, Geriatrics Division, Hennepin County Medical Center, Minneapolis, MN, USA
    Am J Kidney Dis 50:270-8. 2007
    ..Although cognitive function in hemodialysis patients is believed to be best 24 hours after the dialysis session, the extent of variation during the dialysis cycle is unknown...
  93. ncbi request reprint Pneumonia in incident dialysis patients--the United States Renal Data System
    Haifeng Guo
    United States Renal Data System Coordinating Center, Minneapolis, MN 55404, USA
    Nephrol Dial Transplant 23:680-6. 2008
    ..Although clinical experience suggests that pneumonia may occur frequently in dialysis patients, its clinical epidemiology in that group remains poorly defined...